Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Potent PAI-1 inhibitors discovered by ADIR scientists

May 25, 2001

GlycoDesign and Leo select antithrombotic drug candidates

May 22, 2001

Adhesion receptor antagonists reported by Merck as useful in thrombotic disorders

May 22, 2001

ConjuChem completes phase I trial of anticlotting compound

May 17, 2001

Carafiban maleate, an orally active fibrinogen antagonist with clinical potential

May 17, 2001

Meiji Seika's new phosphonic acid derivatives particularly useful in thrombotic disorders

May 16, 2001

Cor patents new series of factor Xa inhibitors with high potency and selectivity

May 16, 2001

Bivalent FVIIa/TF/FXa complex inhibitors

May 15, 2001

UR-3216 emerges as a promising new gpIIb/IIIa antagonist for cardiovascular disorders

May 14, 2001

Direct thrombin inhibitor LB-30057 compared with inogatran in rabbit thrombosis model

May 11, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...